. . "Valganciclovir ist ein Virostatikum aus der Gruppe der Nucleosidanaloga. Es ist der L-Valinylester von Ganciclovir und fungiert als Resorptionsester: w\u00E4hrend Ganciclovir infudiert werden muss, wird Valganciclovir nach peroraler Verabreichung gut resorbiert und verf\u00FCgt \u00FCber eine hohe Bioverf\u00FCgbarkeit. Nach Resorption wird Valganciclovir im K\u00F6rper zu dem eigentlich wirksamen Ganciclovir umgewandelt. Valganciclovir wird als Hydrochlorid als Arzneistoff im Medikament Valcyte\u00AE (Roche) zur Behandlung der Cytomegalievirusretinitis bei Aids-Patienten verwendet."@de . . . "El valganciclovir es un antiviral utilizado para el tratamiento de las infecciones causadas por citomegalovirus, especialmente para las retinitis causadas por este tipo de virus en pacientes inmunodeprimidos como los enfermos de VIH/SIDA y las neumon\u00EDas causadas por estos virus en pacientes que han recibido un trasplante. Es el \u00E9ster conformado entre el ganciclovir y el amino\u00E1cido valina. \n* Datos: Q423384 \n* Multimedia: Valganciclovir / Q423384"@es . . . . . . . "changed"@en . . . "1"^^ . . . . "a605021"@en . . . "D02495"@en . "\u30D0\u30EB\u30AC\u30F3\u30B7\u30AF\u30ED\u30D3\u30EB\uFF08Valganciclovir\uFF09\u306F\u3001\u30B5\u30A4\u30C8\u30E1\u30AC\u30ED\u30A6\u30A4\u30EB\u30B9\u306B\u5BFE\u3059\u308B\u6297\u30A6\u30A4\u30EB\u30B9\u85AC\u306E\u4E00\u3064\u3067\u3042\u308B\u3002\u30AC\u30F3\u30B7\u30AF\u30ED\u30D3\u30EB\u3092L-\u30D0\u30EA\u30F3\u3067\u30A8\u30B9\u30C6\u30EB\u5316\u3057\u3001\u30D7\u30ED\u30C9\u30E9\u30C3\u30B0\u3068\u3057\u305F\u3082\u306E\u3067\u3042\u308B\u3002\u5546\u54C1\u540D\u30D0\u30EA\u30AD\u30B5\u3002"@ja . "\u0641\u0627\u0644 \u0642\u0627\u0646\u0633\u064A\u0643\u0644\u0648\u0641\u064A\u0631 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Valganciclovir)\u200F \u0647\u0648 \u062F\u0648\u0627\u0621 \u0645\u0636\u0627\u062F \u0644\u0644\u0641\u064A\u0631\u0648\u0633\u0627\u062A \u064A\u0633\u062A\u062E\u062F\u0645 \u0644\u0639\u0644\u0627\u062C \u0627\u0644\u062A\u0647\u0627\u0628\u0627\u062A \u0641\u064A\u0631\u0648\u0633 \u0645\u0636\u062E\u0645 \u0644\u0644\u062E\u0644\u0627\u064A\u0627 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: CMV)\u200F."@ar . . . "Walgancyklowir (\u0142ac. valganciclovirum) \u2013 wielofunkcyjny organiczny zwi\u0105zek chemiczny, ester L-walinowy gancyklowiru, stosowany jako prolek w zapobieganiu i leczeniu infekcji wirusem cytomegalii (CMV) u pacjent\u00F3w z niedoborem odporno\u015Bci."@pl . "Valganciclovir \u00E8 una molecola ad attivit\u00E0 antivirale. La molecola \u00E8 un profarmaco di ganciclovir, ed \u00E8 utilizzata per trattare o prevenire le infezioni da citomegalovirus con il blocco della sua replicazione mediante l'inibizione della sintesi del DNA virale. In Italia il farmaco \u00E8 venduto dalla societ\u00E0 farmaceutica Roche con il nome commerciale di Valcyte nella forma farmacologica di polvere per soluzione orale (una volta ricostituita la soluzione contiene 50 mg di valganciclovir per ogni ml)."@it . . . . "Walgancyklowir (\u0142ac. valganciclovirum) \u2013 wielofunkcyjny organiczny zwi\u0105zek chemiczny, ester L-walinowy gancyklowiru, stosowany jako prolek w zapobieganiu i leczeniu infekcji wirusem cytomegalii (CMV) u pacjent\u00F3w z niedoborem odporno\u015Bci."@pl . "Valcyte, Valcip, others"@en . . . . "D"@en . . . "Valgansiklovir atau yang juga biasa dipasarkan dengan nama valcyte adalah obat antivirus yang digunakan dalam penanganan dan pencegahan penyakit yang disebabkan oleh sitomegalovirus pada pasien penderita AIDS atau penerima donor organ. Obat ini termasuk dalam salah satu Daftar Obat Esensial Organisasi Kesehatan Dunia."@in . "Valganciclovir"@de . . . "Valgansiklovir"@in . "461740941"^^ . . . "1"^^ . . "2399315"^^ . . "Valcyte, Valcip, others"@en . "\u0412\u0430\u043B\u0433\u0430\u043D\u0446\u0438\u043A\u043B\u043E\u0432\u0456\u0301\u0440 \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043F\u0440\u043E\u0442\u0438\u0432\u0456\u0440\u0443\u0441\u043D\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442 \u0437 \u0433\u0440\u0443\u043F\u0438 \u0434\u043B\u044F \u043F\u0435\u0440\u043E\u0440\u0430\u043B\u044C\u043D\u043E\u0433\u043E \u0437\u0430\u0441\u0442\u043E\u0441\u0443\u0432\u0430\u043D\u043D\u044F. \u0412\u0430\u043B\u0433\u0430\u043D\u0446\u0438\u043A\u043B\u043E\u0432\u0456\u0440 \u0440\u043E\u0437\u0440\u043E\u0431\u043B\u0435\u043D\u0438\u0439 \u0448\u0432\u0435\u0439\u0446\u0430\u0440\u0441\u044C\u043A\u043E\u044E \u043A\u043E\u043C\u043F\u0430\u043D\u0456\u0454\u044E \u00ABHoffmann-La Roche\u00BB, \u044F\u043A\u0430 \u0432\u0438\u043F\u0443\u0441\u043A\u0430\u0454 \u0439\u043E\u0433\u043E \u043F\u0456\u0434 \u0442\u043E\u0440\u0433\u043E\u0432\u0435\u043B\u044C\u043D\u043E\u044E \u043D\u0430\u0437\u0432\u043E\u044E \u00AB\u0412\u0430\u043B\u044C\u0446\u0438\u0442\u00BB."@uk . . . . . . . . . . . "Valgansiklovir atau yang juga biasa dipasarkan dengan nama valcyte adalah obat antivirus yang digunakan dalam penanganan dan pencegahan penyakit yang disebabkan oleh sitomegalovirus pada pasien penderita AIDS atau penerima donor organ. Obat ini termasuk dalam salah satu Daftar Obat Esensial Organisasi Kesehatan Dunia."@in . . . . . . . . "\u30D0\u30EB\u30AC\u30F3\u30B7\u30AF\u30ED\u30D3\u30EB"@ja . . "1201314"^^ . . . "14400.0"^^ . . "14"^^ . . . "DB01610"@en . . . "6"^^ . "J05"@en . . . . . . . "Valganciclovir"@es . . . "Valganciclovir"@it . "\u0641\u0627\u0644 \u0642\u0627\u0646\u0633\u064A\u0643\u0644\u0648\u0641\u064A\u0631 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Valganciclovir)\u200F \u0647\u0648 \u062F\u0648\u0627\u0621 \u0645\u0636\u0627\u062F \u0644\u0644\u0641\u064A\u0631\u0648\u0633\u0627\u062A \u064A\u0633\u062A\u062E\u062F\u0645 \u0644\u0639\u0644\u0627\u062C \u0627\u0644\u062A\u0647\u0627\u0628\u0627\u062A \u0641\u064A\u0631\u0648\u0633 \u0645\u0636\u062E\u0645 \u0644\u0644\u062E\u0644\u0627\u064A\u0627 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: CMV)\u200F."@ar . . . "N"@en . "changed"@en . . . . . "GCU97FKN3R"@en . . . . . . . . . . . . . . . "135413535" . . "16587"^^ . "175865"^^ . . "Walgancyklowir"@pl . . . . "as HCl"@en . . . . "4716"^^ . . . . . . . "Le valganciclovir est un m\u00E9dicament antiviral agissant comme une prodrogue. Donn\u00E9 par voie orale, il est transform\u00E9 en ganciclovir qui est la mol\u00E9cule active, ciblant le cytom\u00E9galovirus."@fr . "\u7E88\u66F4\u6614\u6D1B\u97CB\uFF08\u82F1\u8A9E\uFF1AValganciclovir\uFF09\uFF0C\u662F\u4E00\u6B3E\u6297\u75C5\u6BD2\u85E5\u7269\uFF0C\u7528\u4EE5\u6CBB\u7642\u56E0\u611B\u6ECB\u75C5\u6216\u5668\u5B98\u79FB\u690D\u9020\u6210\u5DE8\u7D30\u80DE\u75C5\u6BD2\u611F\u67D3\uFF0C\u4EE3\u8868\u6027\u7684\u85E5\u54C1\u54C1\u540D\u70BA Valcyte \u3002\u672C\u54C1\u53EA\u80FD\u58D3\u5236\u611F\u67D3\uFF0C\u7121\u6CD5\u6CBB\u7652\uFF0C\u9700\u9577\u671F\u4F7F\u7528\u3002\u6B64\u85E5\u662F\u53E3\u670D\u7D66\u85E5\u3002 \u5E38\u898B\u7684\u526F\u4F5C\u7528\u70BA\u8179\u75DB\u3001\u982D\u75DB\u3001\u5931\u7720\u3001\u5641\u5FC3\u3001\u767C\u71D2\u53CA\u3002\u5176\u4ED6\u7684\u526F\u4F5C\u7528\u6709\u4E0D\u5B55\u53CA\u814E\u529F\u80FD\u8870\u7AED\u3002\u6709\u4E9B\u52D5\u7269\u5728\u61F7\u5B55\u6642\u4F7F\u7528\u6B64\u85E5\uFF0C\u9020\u6210\u4E86\u751F\u80B2\u7F3A\u9677\u3002\u672C\u54C1\u662F\u66F4\u6614\u6D1B\u97CB\u7684L-\u7E88\u6C28\u91AF\u916F\uFF0C\u5230\u8178\u9053\u53CA\u809D\u81DF\u6642\u6703\u5206\u89E3\u70BA\u66F4\u6614\u6D1B\u97CB\u3002 \u7E88\u66F4\u6614\u6D1B\u97CB\u5728 2001 \u5E74\u901A\u904E\u91AB\u7642\u7528\u9014\uFF0C\u5217\u65BC\u4E16\u754C\u885B\u751F\u7D44\u7E54\u57FA\u672C\u85E5\u7269\u6A19\u6E96\u6E05\u55AE\uFF0C\u8A8D\u53EF\u70BA\u91AB\u7642\u7CFB\u7D71\u4E2D\u5B89\u5168\u6709\u6548\u7684\u5FC5\u9700\u85E5\u7269\u3002\u5728\u958B\u767C\u4E2D\u570B\u5BB6\uFF0C\u6BCF\u65E5\u85E5\u8CBB\u7D04\u5728 30.16 \u81F3 52.14 \u7F8E\u5143\u4E4B\u9593\u30022016\u5E74\u6642\uFF0C\u5728\u7F8E\u570B\uFF0C\u5E73\u5747\u6BCF\u65E5\u6279\u767C\u50F9\u70BA 58.54 \u7F8E\u5143\u30022017\u5E74\uFF0C\u5176\u901A\u7528\u540D\u85E5\u7269\u901A\u904E\u6838\u53EF[6]\u3002"@zh . . . . . . . . . . . "Valganciclovir"@en . . . . . . . . . . . . . "\u30D0\u30EB\u30AC\u30F3\u30B7\u30AF\u30ED\u30D3\u30EB\uFF08Valganciclovir\uFF09\u306F\u3001\u30B5\u30A4\u30C8\u30E1\u30AC\u30ED\u30A6\u30A4\u30EB\u30B9\u306B\u5BFE\u3059\u308B\u6297\u30A6\u30A4\u30EB\u30B9\u85AC\u306E\u4E00\u3064\u3067\u3042\u308B\u3002\u30AC\u30F3\u30B7\u30AF\u30ED\u30D3\u30EB\u3092L-\u30D0\u30EA\u30F3\u3067\u30A8\u30B9\u30C6\u30EB\u5316\u3057\u3001\u30D7\u30ED\u30C9\u30E9\u30C3\u30B0\u3068\u3057\u305F\u3082\u306E\u3067\u3042\u308B\u3002\u5546\u54C1\u540D\u30D0\u30EA\u30AD\u30B5\u3002"@ja . . "POM"@en . "\u7F2C\u66F4\u6614\u6D1B\u97E6"@zh . . . "1123118224"^^ . "GCU97FKN3R" . . "Valganciclovir, sold under the brand name Valcyte among others, is an antiviral medication used to treat cytomegalovirus (CMV) infection in those with HIV/AIDS or following organ transplant. It is often used long term as it only suppresses rather than cures the infection. Valganciclovir is taken by mouth. Common side effects include abdominal pain, headaches, trouble sleeping, nausea, fever, and low blood cell counts. Other side effects may include infertility and kidney problems. When used during pregnancy, it causes birth defects in some animals. Valganciclovir is the L-valyl ester of ganciclovir and works when broken down into ganciclovir by the intestine and liver. Valganciclovir was approved for medical use in 2001. It is on the World Health Organization's List of Essential Medicines. In 2017, a generic version was approved."@en . . . . . . . . . . . . . . . "\u0412\u0430\u043B\u0433\u0430\u043D\u0446\u0438\u043A\u043B\u043E\u0432\u0456\u0440"@uk . . "WPVFJKSGQUFQAP-GKAPJAKFSA-N"@en . "Valganciclovir"@pt . . . . . . . . . . . "F9E"@en . . . . . . . . . . . "57721"^^ . "Rx-only"@en . . . . . . . . . . . . "a605021" . "2"^^ . . "Valganciclovir"@en . . . . . . . . . . "32967"^^ . . . "135413535"^^ . . . . . "Hydrolysed to ganciclovir"@en . . . . . . . "5"^^ . . "D02495" . . . . "\u0412\u0430\u043B\u0433\u0430\u043D\u0446\u0438\u043A\u043B\u043E\u0432\u0456\u0301\u0440 \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043F\u0440\u043E\u0442\u0438\u0432\u0456\u0440\u0443\u0441\u043D\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442 \u0437 \u0433\u0440\u0443\u043F\u0438 \u0434\u043B\u044F \u043F\u0435\u0440\u043E\u0440\u0430\u043B\u044C\u043D\u043E\u0433\u043E \u0437\u0430\u0441\u0442\u043E\u0441\u0443\u0432\u0430\u043D\u043D\u044F. \u0412\u0430\u043B\u0433\u0430\u043D\u0446\u0438\u043A\u043B\u043E\u0432\u0456\u0440 \u0440\u043E\u0437\u0440\u043E\u0431\u043B\u0435\u043D\u0438\u0439 \u0448\u0432\u0435\u0439\u0446\u0430\u0440\u0441\u044C\u043A\u043E\u044E \u043A\u043E\u043C\u043F\u0430\u043D\u0456\u0454\u044E \u00ABHoffmann-La Roche\u00BB, \u044F\u043A\u0430 \u0432\u0438\u043F\u0443\u0441\u043A\u0430\u0454 \u0439\u043E\u0433\u043E \u043F\u0456\u0434 \u0442\u043E\u0440\u0433\u043E\u0432\u0435\u043B\u044C\u043D\u043E\u044E \u043D\u0430\u0437\u0432\u043E\u044E \u00AB\u0412\u0430\u043B\u044C\u0446\u0438\u0442\u00BB."@uk . . . "Valganciclovir \u00E9 um pr\u00F3-f\u00E1rmaco utilizado pela medicina como antiviral, no tratamento e profilaxia da retinite por citomegalov\u00EDrus em portadores do v\u00EDrus HIV."@pt . . . . . . . "Valganciclovir ball-and-stick.png"@en . . . . "AB14"@en . . "\u0641\u0627\u0644 \u0642\u0627\u0646\u0633\u064A\u0643\u0644\u0648\u0641\u064A\u0631"@ar . . . . . . "\u7E88\u66F4\u6614\u6D1B\u97CB\uFF08\u82F1\u8A9E\uFF1AValganciclovir\uFF09\uFF0C\u662F\u4E00\u6B3E\u6297\u75C5\u6BD2\u85E5\u7269\uFF0C\u7528\u4EE5\u6CBB\u7642\u56E0\u611B\u6ECB\u75C5\u6216\u5668\u5B98\u79FB\u690D\u9020\u6210\u5DE8\u7D30\u80DE\u75C5\u6BD2\u611F\u67D3\uFF0C\u4EE3\u8868\u6027\u7684\u85E5\u54C1\u54C1\u540D\u70BA Valcyte \u3002\u672C\u54C1\u53EA\u80FD\u58D3\u5236\u611F\u67D3\uFF0C\u7121\u6CD5\u6CBB\u7652\uFF0C\u9700\u9577\u671F\u4F7F\u7528\u3002\u6B64\u85E5\u662F\u53E3\u670D\u7D66\u85E5\u3002 \u5E38\u898B\u7684\u526F\u4F5C\u7528\u70BA\u8179\u75DB\u3001\u982D\u75DB\u3001\u5931\u7720\u3001\u5641\u5FC3\u3001\u767C\u71D2\u53CA\u3002\u5176\u4ED6\u7684\u526F\u4F5C\u7528\u6709\u4E0D\u5B55\u53CA\u814E\u529F\u80FD\u8870\u7AED\u3002\u6709\u4E9B\u52D5\u7269\u5728\u61F7\u5B55\u6642\u4F7F\u7528\u6B64\u85E5\uFF0C\u9020\u6210\u4E86\u751F\u80B2\u7F3A\u9677\u3002\u672C\u54C1\u662F\u66F4\u6614\u6D1B\u97CB\u7684L-\u7E88\u6C28\u91AF\u916F\uFF0C\u5230\u8178\u9053\u53CA\u809D\u81DF\u6642\u6703\u5206\u89E3\u70BA\u66F4\u6614\u6D1B\u97CB\u3002 \u7E88\u66F4\u6614\u6D1B\u97CB\u5728 2001 \u5E74\u901A\u904E\u91AB\u7642\u7528\u9014\uFF0C\u5217\u65BC\u4E16\u754C\u885B\u751F\u7D44\u7E54\u57FA\u672C\u85E5\u7269\u6A19\u6E96\u6E05\u55AE\uFF0C\u8A8D\u53EF\u70BA\u91AB\u7642\u7CFB\u7D71\u4E2D\u5B89\u5168\u6709\u6548\u7684\u5FC5\u9700\u85E5\u7269\u3002\u5728\u958B\u767C\u4E2D\u570B\u5BB6\uFF0C\u6BCF\u65E5\u85E5\u8CBB\u7D04\u5728 30.16 \u81F3 52.14 \u7F8E\u5143\u4E4B\u9593\u30022016\u5E74\u6642\uFF0C\u5728\u7F8E\u570B\uFF0C\u5E73\u5747\u6BCF\u65E5\u6279\u767C\u50F9\u70BA 58.54 \u7F8E\u5143\u30022017\u5E74\uFF0C\u5176\u901A\u7528\u540D\u85E5\u7269\u901A\u904E\u6838\u53EF[6]\u3002"@zh . . . "60.0"^^ . . "175865-60-8" . . . . "250"^^ . . . . "Valganciclovir, sold under the brand name Valcyte among others, is an antiviral medication used to treat cytomegalovirus (CMV) infection in those with HIV/AIDS or following organ transplant. It is often used long term as it only suppresses rather than cures the infection. Valganciclovir is taken by mouth. Valganciclovir was approved for medical use in 2001. It is on the World Health Organization's List of Essential Medicines. In 2017, a generic version was approved."@en . . "Valganciclovir"@fr . . "Valganciclovir \u00E8 una molecola ad attivit\u00E0 antivirale. La molecola \u00E8 un profarmaco di ganciclovir, ed \u00E8 utilizzata per trattare o prevenire le infezioni da citomegalovirus con il blocco della sua replicazione mediante l'inibizione della sintesi del DNA virale. In Italia il farmaco \u00E8 venduto dalla societ\u00E0 farmaceutica Roche con il nome commerciale di Valcyte nella forma farmacologica di polvere per soluzione orale (una volta ricostituita la soluzione contiene 50 mg di valganciclovir per ogni ml)."@it . . . . "60.0"^^ . . "Le valganciclovir est un m\u00E9dicament antiviral agissant comme une prodrogue. Donn\u00E9 par voie orale, il est transform\u00E9 en ganciclovir qui est la mol\u00E9cule active, ciblant le cytom\u00E9galovirus."@fr . "22"^^ . . . "1201314" . . "D03256" . "D03256"@en . . . . "El valganciclovir es un antiviral utilizado para el tratamiento de las infecciones causadas por citomegalovirus, especialmente para las retinitis causadas por este tipo de virus en pacientes inmunodeprimidos como los enfermos de VIH/SIDA y las neumon\u00EDas causadas por estos virus en pacientes que han recibido un trasplante. Es el \u00E9ster conformado entre el ganciclovir y el amino\u00E1cido valina. Su modo de acci\u00F3n es el mismo que el del ganciclovir. La diferencia radica en su v\u00EDa de administraci\u00F3n que es oral, lo cual permite que sea f\u00E1cilmente transformada en ganciclovir por acci\u00F3n de las enzimas hep\u00E1ticas e intestinales llamadas esterasas; adem\u00E1s, su biodisponibilidad es mucho mayor que la del ganciclovir. Los efectos adversos que presenta son granulocitopenia, trombocitopenia, neutropenia, anemia, fiebre, n\u00E1useas, v\u00F3mito, dispepsia, diarrea, anorexia, pero la mielosupresi\u00F3n es la m\u00E1s destacable. Recientemente, la Universidad de Stanford en California ha desarrollado un estudio que propone al valganciclovir como medicamento eficaz contra el s\u00EDndrome de fatiga cr\u00F3nica. Estos estudios se est\u00E1n realizando desde inicios de 2007. \n* Datos: Q423384 \n* Multimedia: Valganciclovir / Q423384"@es . "O=C[C@@H]CC"@en . . "Valganciclovir ist ein Virostatikum aus der Gruppe der Nucleosidanaloga. Es ist der L-Valinylester von Ganciclovir und fungiert als Resorptionsester: w\u00E4hrend Ganciclovir infudiert werden muss, wird Valganciclovir nach peroraler Verabreichung gut resorbiert und verf\u00FCgt \u00FCber eine hohe Bioverf\u00FCgbarkeit. Nach Resorption wird Valganciclovir im K\u00F6rper zu dem eigentlich wirksamen Ganciclovir umgewandelt. Valganciclovir wird als Hydrochlorid als Arzneistoff im Medikament Valcyte\u00AE (Roche) zur Behandlung der Cytomegalievirusretinitis bei Aids-Patienten verwendet. Valganciclovir weist als Prodrug des Ganciclovir die gleichen Wirkungen und Nebenwirkungen wie dieses auf. Es sind dies z. T. lebensbedrohliche St\u00F6rungen. Es wird \u00FCber Neutropenie bis hin zur Agranulozytose, An\u00E4mie, Thrombozytopenie, Durchfall, Erbrechen, Bauchschmerzen, Kopfschmerz, Neuropathien und Leberzellsch\u00E4den im Zusammenhang mit der Einnahme von Valganciclovir berichtet. Es soll daher nur bei lebens- oder augenlichtbedrohenden Infektionen angewendet werden."@de . . . "DB01610" . . . . . . "Valganciclovir \u00E9 um pr\u00F3-f\u00E1rmaco utilizado pela medicina como antiviral, no tratamento e profilaxia da retinite por citomegalov\u00EDrus em portadores do v\u00EDrus HIV."@pt . . .